ISSN: 0003-4509

Journal Home

Journal Guideline

Annales Pharmaceutiques Francaises Q3 Unclaimed

Elsevier Masson s.r.l. France

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annales Pharmaceutiques Francaises is a journal indexed in SJR in Pharmacology and Pharmaceutical Science with an H index of 31. It has an SJR impact factor of 0,219 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,219.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q3) Pharmacology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,219

SJR Impact factor

31

H Index

106

Total Docs (Last Year)

218

Total Docs (3 years)

4018

Total Refs

228

Total Cites (3 years)

213

Citable Docs (3 years)

1.01

Cites/Doc (2 years)

37.91

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Toxicology Q3
Journal of Antibiotics Q3
Human Psychopharmacology Q3
Current molecular pharmacology Q3
Journal of Physiology and Pharmacology Q3

Compare this journals

Aims and Scope

Best articles by citations

MRI gadolinium-based contrast agents. Radiologists beware!

Securisation de la prise en charge medicamenteuse : cartographie des risques a priori au sein du service de chirurgie orthopedique

Physical stability of highly concentrated injectable drugs solutions used in intensive care units

L'education therapeutique du patient (ETP). Points de reperes et perspectives

Les traitements de substitution aux opiaces : bilan des politiques publiques

Les traitements de substitution aux opiaces en France

Actualites de la legislation europeenne en matiere d'aliments et d'allegations sante

Aspects specifiques de la production dans le domaine des vaccins

Assessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates

Principes et applications therapeutiques de la phototherapie dynamique

Value and payment for oncology in the United States

FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics

SHOW MORE ARTICLES

La consultation pharmaceutique en transplantation hepatique : une contribution a l'education therapeutique des patients

Exactitude, precision et rapidite de fabrication des poches de melanges nutritifs parenteraux : comparaison de techniques automatisee et manuelle

Improvement of the anti-proliferative activity of the peptide ERa17p in MCF-7 breast cancer cells using nanodiamonds

Comparaison entre le co?ªt d'une pose de catheter veineux central d'insertion peripherique et d'une chambre implantable

Lait falsifie par la melamine : un autre scandale de sante publique

Amine oxidases of the quinoproteins family: Their implication in the metabolic oxidation of xenobiotics

Nouvelles perspectives d'utilisation des hepatocytes humains au cours du developpement preclinique des medicaments

Erratum to "MRI gadolinium-based contrast agents. Radiologists beware!" [Ann Pharm Fr 2009;67:335-9]

Troubles psychiatriques et ganglions de la base : une validation experimentale

La phytovigilance : imperatif medical et obligation legale

Synthesis of new oxadiazole, pyrazole and pyrazolin-5-one bearing 2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)acetohydrazide analogs as potential antibacterial and antifungal agents

Nicolas Lemery, apothicaire et chimiste